Profile
Bruce Neri has been Vice President of Diagnostic Research and Development for Prometheus Laboratories, Inc. since March 2004.
Prior to joining Prometheus, he was Senior Vice President of Research and Development for Third Wave Technologies, Inc. from July 1996 to March 2004.
Before that Dr. Neri was Vice President of DNA Probe Development for Becton, Dickinson and Company.
Previously, he was Director of Research and Development for Gene-Trak Systems, Angenics, Inc., Instrumentation Laboratories and Abbott Laboratories.
Dr. Neri received a BA degree in Chemistry from Cornell University and a PhD in Analytical Chemistry from the University of Arizona.
Former positions of Bruce P. Neri
| Companies | Position | End |
|---|---|---|
Third Wave Technologies, Inc.
 Third Wave Technologies, Inc. BiotechnologyHealth Technology Third Wave Technologies, Inc. developed DNA and RNA detection technology. It provided molecular solutions for clinical, research, and agricultural customers. The company was founded in February 1993 and was headquartered in Madison, WI. | Chief Tech/Sci/R&D Officer | 2004-02-29 |
| BECTON, DICKINSON AND COMPANY | Corporate Officer/Principal | 1995-12-31 |
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
| ABBOTT LABORATORIES | Chief Tech/Sci/R&D Officer | - |
Instrumentation Laboratory Co.
 Instrumentation Laboratory Co. Medical SpecialtiesHealth Technology Instrumentation Laboratory Co. manufactures diagnostic products. It offers critical care systems, hemostatis products and information management services. The firm provides services to the hospitals and clinical laboratories. Instrumentation Laboratory was founded in 1959 and is headquartered in Bedford, MA. | Chief Tech/Sci/R&D Officer | - |
Training of Bruce P. Neri
| Cornell University | Undergraduate Degree |
| University of Arizona | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| BECTON, DICKINSON AND COMPANY | Health Technology |
| ABBOTT LABORATORIES | Health Technology |
| Private companies | 4 |
|---|---|
Third Wave Technologies, Inc.
Third Wave Technologies, Inc. BiotechnologyHealth Technology Third Wave Technologies, Inc. developed DNA and RNA detection technology. It provided molecular solutions for clinical, research, and agricultural customers. The company was founded in February 1993 and was headquartered in Madison, WI. | Health Technology |
Gene Trak Systems
 Gene Trak Systems Medical SpecialtiesHealth Technology Part of Neogen Corp., Gene Trak Systems is an American company that provides food testing services using innovative DNA probe-based products for bacterial contaminants. Gene Trak Systems was acquired by Neogen Corp. from Abbott Molecular, Inc. on August 06, 2001 for $3.50 million. | Health Technology |
Instrumentation Laboratory Co.
Instrumentation Laboratory Co. Medical SpecialtiesHealth Technology Instrumentation Laboratory Co. manufactures diagnostic products. It offers critical care systems, hemostatis products and information management services. The firm provides services to the hospitals and clinical laboratories. Instrumentation Laboratory was founded in 1959 and is headquartered in Bedford, MA. | Health Technology |
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Bruce P. Neri
